Human medicines European public assessment report (EPAR): Fylrevy, estetrol, Date of authorisation: 26/03/2026, Status: Authorised
Union Product Database
We are delighted to announce that the 25th edition of the European Congress of Internal Medicine (ECIM 2027) will take place in Paris from 31 March to 3 April 2027.
Join us at the iconic Cité des sciences et de l'industrie for an enriching and engaging scientific experience. The congress will feature a comprehensive programme including scientific sessions, keynote lectures, interactive workshops, clinical case discussions, and poster presentations.
Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Withdrawn
Core summary of product characteristics for human normal immunoglobulin for subcutaneous and intramuscular use - Scientific guideline
Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline
Template for sharing EMA documents by Industry to support reliance
Clinical Trial Information System (CTIS) - Sponsor Frequently Asked Questions (FAQ)
We are pleased to share that ECIM 2026 has been featured in six articles published on Medscape. These articles showcase the different scientific discussions and research presented during the congress.
The Medscape coverage reflects the relevance and impact of the presentations delivered at the ECIM 2026, helping expand their visbility to a wider audience.
Please find the Medscape articles in the link below:
List of medicines currently in PRIME scheme